Food and Drug Administration News

Date Posted
Article Title
3/3/2006
Erbitux Approved to Treat Head and Neck Cancers

First new drug for these types of cancer in decades

3/3/2006
Controversial MS Drug Trial Flawed, Experts Say

Woman who died from rare infection shouldn't have been part of Tysabri study in first place, they note

3/1/2006
Studies Suggest Controversial Multiple Sclerosis Drug Is Safe

But some risk exists so more evaluation is needed, experts say

3/1/2006
Cancer Drug Approved for Rheumatoid Arthritis

In cases where other drugs don't work

3/1/2006
First Skin Patch to Treat Depression

Higher doses require dietary restrictions

2/23/2006
First Generic Version of Flonase Approved

Treats nasal allergy symptoms

2/21/2006
Antifungal Treatment Wins FDA Approval

Eraxis fights deadly blood infections common at hospitals

2/21/2006
Health Tip: Are Artificial Sweeteners Safe?

FDA elaborates on saccharin and aspartame

2/17/2006
FDA Approved Controversial MS Drug Too Quickly: Expert

But others say Tysabri, now withdrawn from market, met standard data requirements

2/17/2006
Birth-Control Patch May Boost Risk of Blood Clots

But a second study found no heightened risk, officials report

2/17/2006
U.S. Allows Withdrawn MS Drug to Return in Clinical Trial

FDA to consider Tysabri's full return to market next month

2/16/2006
Health Tip: Avoid Needless Ultrasounds of Fetus

FDA says they could be dangerous

2/14/2006
New Weight-Loss Drug Shows Promise

Trial results look good, but experts say rimonabant isn't a 'magic bullet'

2/13/2006
Vaccine Approved to Protect Children From Rotavirus

Prevents leading cause of diarrhea in kids

2/9/2006
FDA Panel Calls for Strongest Warning on ADHD Drugs

In close vote, committee recommends 'black box' label for methylphenidates such as Ritalin

2/3/2006
New Test Quickly Spots Bird Flu in People

It should benefit patients and help control potential outbreaks, officials say

2/1/2006
FDA Approves Inhaled Insulin for Diabetes

Exubera, first drug of its kind, could mean an end to injections for millions with the disease

1/27/2006
Soy Claim as Heart Helper in Dispute

New findings could change FDA rules on claims made by soy products

1/27/2006
Inhaled Insulin Approved for Diabetics

First new delivery option in decades

1/26/2006
New Treatment for Stomach and Kidney Cancers

Deprives tumors of blood and nutrients

1/26/2006
FDA Approves New Drug for Two Cancers

Sutent works against stomach and kidney cancers

1/24/2006
Controversial Weight-Loss Drug May Go Over-the-Counter

But as FDA weighs approval, critics voice concerns about Xenical

1/24/2006
FDA Panel Calls for Ban on Some Asthma Inhalers

Certain over-the-counter products contain chemical that can damage ozone layer

1/18/2006
Prescription Drug Labels Get User-Friendly Overhaul

FDA action is designed to help doctors and consumers, officials say

1/17/2006
New Test Spots More Recurrences of Bladder Cancer

Measures key protein found in urine, raises rate of detection of disease

1/16/2006
FDA: Drug Name Confusion Makes Imports Dangerous

Agency warns of prescription mix-ups, but critics suspect an anti-import agenda

1/12/2006
U.S. Moves to Improve Drug-Approval Process

FDA initiatives designed to aid scientists in early stages of research

1/12/2006
Trans Fat on Food Labels: Now You See It, Now You Don't

New FDA rules allow fewer than 0.5 grams of unhealthy fat to not count

1/3/2006
Drug Approved to Prevent Breast Cancer Recurrence

Study shows it's more effective than gold-standard preventive

12/30/2005
Trans Fat Food Labels Are Coming

Starting New Year's Day, labeling also will list potential allergens

12/29/2005
New Treatment Sanctioned for Bone Marrow Disorder

But similar drug known to cause birth defects

12/27/2005
New Rheumatoid Arthritis Drug Approved

Blocks immune system signal

12/23/2005
Tamiflu Approved to Prevent Flu in Kids Under 12

But it's not a substitute for a flu shot, FDA says

12/20/2005
Nexavar Approved for Advanced Kidney Cancer

Disease kills about 12,000 annually

12/19/2005
FDA Recalls Drug Used to Diagnose Appendicitis

NeutroSpec linked to 2 deaths, 20 'life-threatening' reactions, agency says

12/17/2005
'Canadian' Drugs Come From Other Countries: FDA

Four-airport sting operation found drugs shipped from nations like Costa Rica and Israel

12/14/2005
Major Painkiller Trial to Start

Experts concerned that trial is funded by maker of one of the drugs to be studied

12/10/2005
Vioxx Drama Echoes Earlier Concerns About Missing Data

Renewed outrage triggered by medical journal's charge that drug maker withheld heart risks

12/9/2005
New England Journal Charges Merck Deleted Vioxx Study Data

Editors contend drugmaker withheld information on heart risks before findings were given to journal

12/1/2005
Acetaminophen Overdose a Growing Threat

Too much of the active ingredient in Tylenol can cause liver failure, researchers warn

11/30/2005
Abortion Pill Deaths Probed

Battle continues over Mifeprex's safety after rare cases of fatal infection

11/30/2005
Older Antipsychotic Drugs No Safer Than New Ones

Researchers warn about replacing the newer meds that carry warnings

11/18/2005
Doctors Not Heeding 'Black-Box' Warnings on Rx Drugs

For example, many aren't ordering lab tests as indicated on label, study finds

11/10/2005
New Pain Control System Approved

Gives patients more control of medication delivery

11/9/2005
FDA Denies Lycopene Supplement Health Claims

Agency says there's little proof to substantiate cancer-prevention assertions

11/7/2005
Barriers Exist to Optimal Asthma Treatment

They include preferred drug lists and preauthorization policies, studies find

11/3/2005
Merck Wins 2nd Vioxx Lawsuit

Unlike first case, plaintiff failed to prove drug caused his heart attack

11/3/2005
FDA Approves Pancreatic Cancer Drug

Tarceva to be used in combination with gemcitabine chemotherapy

11/3/2005
Direct-to-Consumer Drug Ads Come Under Scrutiny

Widely divergent opinions of their worth emerge at FDA hearings

11/2/2005
Experimental MS Drug Carries Dangers

Risk of fatal brain infection may outweigh Tysabri's benefits, study shows